Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01481571 · ClinicalTrials.gov registry record · NA
Performance Study of New Media for Vitrification of Human Oocytes
A NA study, sponsored by Vitrolife.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT01481571 is a NA study that has completed, run by Vitrolife. The registered enrollment target is 17 participants.
The verdict
NCT01481571, a NA study, has completed, sponsored by Vitrolife.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate safety and performance of Vitrolife´s new oocyte vitrification/warming media and the vitrification device Rapid-i™, when using vitrification as a cryopreservation method for human oocytes.
Interventions
- DEVICE Vitrification medium oocyte, warming medium oocyte and Rapid-i
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2012-01 |
| Est. Completion | 2012-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01481571
The ClinicalTrials.gov registry entry for NCT01481571 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vitrolife, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Vitrification medium oocyte, warming medium oocyte and Rapid-i is the first listed.
NCT01481571 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01481571 about?
NCT01481571 is a clinical study titled "Performance Study of New Media for Vitrification of Human Oocytes". The purpose of this study is to evaluate safety and performance of Vitrolife´s new oocyte vitrification/warming media and the vitrification device Rapid-i™, when using vitrification as a cryopreservation method for human oocytes.
What is the current status of trial NCT01481571?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2012-01. Estimated completion is 2012-09.
What interventions are being tested in trial NCT01481571?
The interventions under investigation include: Vitrification medium oocyte, warming medium oocyte and Rapid-i (DEVICE).
Who is sponsoring clinical trial NCT01481571?
This trial is sponsored by Vitrolife, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.